Jan 22, 2020 - Abbott Laboratories (NYSE:ABT) Q4 2019 Earnings Conference Call January 22, 2020 09:30 ET Company Participants Scott Leinenweber - VP, IR, Licensing & Acquisitions Miles White - Chairman & CEO
Jan 22, 2020 - ABT earnings call for the period ending December 31, 2019.
Jan 22, 2020 - Certain weeks of the year are rife with important information for the stock market. This is not one of those weeks.
Jan 22, 2020 - We are upbeat about Abbott's (ABT) strong and consistent EPD and Medical Devices performances, organically.
Jan 20, 2020 - Abbott's (ABT) imminent quarterly results are expected to reflect a solid performance by the Established Pharmaceuticals Division (EPD) business alike the last reported quarter.
Jan 16, 2020 - Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.
Jan 15, 2020 - Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jan 08, 2020 - Abbott's (ABT) less invasive approach for heart surgery for its heart pump gets the FDA clearance, thus paving the way for avoiding open heart surgeries.
Dec 29, 2019 - These three healthcare stocks have all the ingredients needed to cook up great returns in the new year.
Dec 27, 2019 - The stock market continued its end of the year rally Friday as the three major indices all hit new intraday highs.